The molecular pathology of central neurocytomas
暂无分享,去创建一个
[1] Eric C. Holland,et al. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma , 2010, Nature Reviews Cancer.
[2] Kevin J. Wu,et al. Interphase Cytogenetics for 1p19q and t(1;19)(q10;p10) may Distinguish Prognostically Relevant Subgroups in Extraventricular Neurocytoma , 2009, Brain pathology.
[3] Borivoj Vojtesek,et al. Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment , 2008, Journal of cellular and molecular medicine.
[4] H. Kettenmann,et al. Human central neurocytoma cells show neuronal physiological properties in vitro , 2009, Acta Neuropathologica.
[5] J. Shinoda,et al. Immunohistochemical Study Concerning the Origin of Neurocytoma—A Case Report , 2009, Pathology and Oncology Research.
[6] V. Rohde,et al. Nogo-A Expression in Glial CNS Tumors: A Tool to Differentiate Between Oligodendrogliomas and Other Gliomas? , 2008, The American journal of surgical pathology.
[7] S. G. Malakho,et al. Fast detection of MYCN copy number alterations in brain neuronal tumors by real‐time PCR , 2008, Journal of clinical laboratory analysis.
[8] M. Scott,et al. Insulin-like Growth Factor 2 Is Required for Progression to Advanced Medulloblastoma in patched 1 Heterozygous Mice , 2008 .
[9] F. Révillion,et al. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] H. Arai,et al. Ganglioneurocytoma: Distinctive variant of central neurocytoma , 2007, Pathology international.
[11] B. Scheithauer,et al. Central neurocytoma: management recommendations based on a 35-year experience. , 2007, International journal of radiation oncology, biology, physics.
[12] Zora Modrusan,et al. Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma , 2007, Proceedings of the National Academy of Sciences.
[13] J. Greenfield,et al. Neurocytoma Is a Tumor of Adult Neuronal Progenitor Cells , 2007 .
[14] F. Henderson,et al. Oligodendroglioma with neurocytic differentiation versus atypical extraventricular neurocytoma: a case report of unusual pathologic findings of a spinal cord tumor , 2007, Journal of Neuro-Oncology.
[15] A. Korshunov,et al. Recurrent cytogenetic aberrations in central neurocytomas and their biological relevance , 2007, Acta Neuropathologica.
[16] J. Bottenstein,et al. Neuregulin 1 growth factors regulate proliferation but not apoptosis of a CNS neuronal progenitor cell line , 2006, Brain Research.
[17] R. Delfini,et al. Central neurocytoma: a novel appraisal of a polymorphic pathology Our experience and a review of the literature , 2006, Neurosurgical Review.
[18] H. Heinzl,et al. Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology , 2006, Histopathology.
[19] H. T. Ghashghaei,et al. The role of neuregulin-ErbB4 interactions on the proliferation and organization of cells in the subventricular zone. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Deimling,et al. 45‐ YEAR‐OLD MALE WITH SYMPTOMATIC MASS IN THE FRONTAL LOBE , 2006, Brain pathology.
[21] M. Mut,et al. Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma. , 2005, Clinical neuropathology.
[22] D. Prayer,et al. Recurrent central neurocytomas , 2005, Cancer.
[23] A. Pession,et al. The MYCN oncogene as a specific and selective drug target for peripheral and central nervous system tumors. , 2005, Current cancer drug targets.
[24] U. Schüller,et al. Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells. , 2005, The American journal of pathology.
[25] B. Feuerstein,et al. Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas , 2005, Genes, chromosomes & cancer.
[26] D. Taruscio,et al. Nonrandom gain of chromosome 7 in central neurocytoma: A chromosomal analysis and fluorescence in situ hybridization study , 2005, Virchows Archiv.
[27] S. Paek,et al. Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma , 2005, Journal of Neuro-Oncology.
[28] K. Park,et al. Cerebral neurocytoma without ganglion cell differentiation , 2005, Acta Neurochirurgica.
[29] N. Boddaert,et al. Fourth ventricle neurocytoma with lipomatous and ependymal differentiation , 2005, Acta Neuropathologica.
[30] H. Okano,et al. Possible Oncogenicity of Subventricular Zone Neural Stem Cells: Case Report , 2004, Neurosurgery.
[31] D. Louis,et al. Atypical extraventricular neurocytoma with oligodendroglioma-like spread and an unusual pattern of chromosome 1p and 19q loss. , 2004, Human pathology.
[32] G. Rao,et al. Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice , 2004, Oncogene.
[33] D. Pfaff,et al. Inhibition of neuronal phenotype by PTEN in PC12 cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[34] S. Paek,et al. Forskolin promotes astroglial differentiation of human central neurocytoma cells , 2004, Experimental & Molecular Medicine.
[35] Mitchel S. Berger,et al. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration , 2004, Nature.
[36] A. Asai,et al. Proliferative activity of central neurocytoma: Measurement of tumor volume doubling time, MIB-1 staining index and bromodeoxyuridine labeling index , 1997, Journal of Neuro-Oncology.
[37] K. Zang,et al. Polysomy of chromosome 7 is correlated with overexpression of the erbB oncogene in human glioblastoma cell lines , 1986, Human Genetics.
[38] S. Tsunoda,et al. Central neurocytoma: immunohistochemical and ultrastructural study , 2004, Acta Neuropathologica.
[39] G. Salamon,et al. Central neurocytoma , 2004, Acta Neuropathologica.
[40] Y. Sugisaki,et al. Central neurocytoma expressing characteristics of ependymal differentiation: electron microscopic findings of two cases , 2003, Medical Electron Microscopy.
[41] G. Brodeur. Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.
[42] A. Hoffman,et al. A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma. , 2003, The Journal of clinical investigation.
[43] D. Brat,et al. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics. , 2003, Frontiers in bioscience : a journal and virtual library.
[44] M. Berker,et al. Neuronal nuclear antigen (NeuN): a new tool in the diagnosis of central neurocytoma. , 2003, Pathology, research and practice.
[45] Juthamas Sukbuntherng,et al. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[46] O. Tachibana,et al. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors. , 2002, Journal of neurosurgery.
[47] D. Rades,et al. Treatment options for central neurocytoma , 2002, Neurology.
[48] R. Eisenman,et al. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. , 2002, Genes & development.
[49] L. Parada,et al. The Molecular and Genetic Basis of Neurological Tumours , 2002, Nature Reviews Cancer.
[50] M. Israel,et al. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. , 2002, Cancer research.
[51] M. Jeffers,et al. Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer. , 2002, Cancer research.
[52] M. Shigemori,et al. The biochemical analysis of neurotransmitters in central neurocytomas. , 2001, International journal of molecular medicine.
[53] Arturo Alvarez-Buylla,et al. A unified hypothesis on the lineage of neural stem cells , 2001, Nature Reviews Neuroscience.
[54] S. Ogino,et al. Comparative Immunohistochemical Study of Insulin-like Growth Factor II and Insulin-like Growth Factor ReceptorType 1 in Pediatric Brain Tumors , 2001, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[55] J. Pang,et al. Central neurocytomas are genetically distinct from oligodendrogliomas and neuroblastomas , 2000, Histopathology.
[56] A. Hui,et al. Detection of chromosomal imbalances in central neurocytomas by using comparative genomic hybridization. , 2000, Journal of neurosurgery.
[57] D. Louis,et al. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. , 2000, Journal of neurosurgery.
[58] B. Scheithauer,et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[59] Daniel A. Lim,et al. Subventricular Zone Astrocytes Are Neural Stem Cells in the Adult Mammalian Brain , 1999, Cell.
[60] I. Mackenzie. Central neurocytoma , 1999, Cancer.
[61] V. Jay,et al. Central neurocytoma: morphological, flow cytometric, polymerase chain reaction, fluorescence in situ hybridization, and karyotypic analyses. Case report. , 1999, Journal of neurosurgery.
[62] Jonas Frisén,et al. Identification of a Neural Stem Cell in the Adult Mammalian Central Nervous System , 1999, Cell.
[63] M. Westphal,et al. Tissue culture of human neurocytomas induces the expression of glial fibrilary acidic protein , 1998, Journal of neurocytology.
[64] W. Marston Linehan,et al. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas , 1998, Nature Genetics.
[65] Ian N. M. Day,et al. Molecules in focus Insulin-like growth factor II (IGF-II) , 1998 .
[66] M. Tamura,et al. In vitro neuronal and glial production and differentiation of human central neurocytoma cells , 1998, Journal of neuroscience research.
[67] 石内勝吾. Central neurocytoma: an immunohistochemical,ultrastructural and cell culture study(神経細胞腫の免疫組織化学的,電子顕微鏡学的及び組織培養学的研究) , 1998 .
[68] I. Day,et al. Insulin-like growth factor II (IGF-II). , 1998, The international journal of biochemistry & cell biology.
[69] K. Kawamoto,et al. Ultrastructural characterization of central neurocytomas using collagen gel culture. , 1998, Ultrastructural pathology.
[70] D. Louis,et al. Chemosensitive gliomas in adults: which ones and why? , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[71] J. Weber,et al. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases , 1997, Nature.
[72] B. Scheithauer,et al. Atypical Central Neurocytoma , 1997, Journal of neuropathology and experimental neurology.
[73] K. Kawamoto,et al. Neuronal and glial characteristics of central neurocytoma: electron microscopical analysis of two cases , 1996, Acta Neuropathologica.
[74] M. Weller,et al. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. , 1995, The Journal of clinical investigation.
[75] M. Westphal,et al. Human neurocytoma cells in culture show characteristics of astroglial differentiation , 1994, Journal of neuroscience research.
[76] B. Wullich,et al. Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET. , 1994, Anticancer research.
[77] Iver Petersen,et al. Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system , 1993, Molecular carcinogenesis.
[78] S. Vandenberg,et al. Cytoskeletal Immunohistochemistry of Central Neurocytomas , 1992, The American journal of surgical pathology.
[79] C. Daumas-Duport,et al. Central Neurocytomas: Critical Evaluation of a Small‐Cell Neuronal Tumor , 1992 .
[80] T. Südhof,et al. Histogenesis and differentiation potential of central neurocytomas. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[81] R. Janzer,et al. Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies. , 1990, Acta neuropathologica.
[82] L. J. Rubinstein,et al. Tumors of the central nervous system , 1972 .